Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V0RS
|
|||
Former ID |
DNC013977
|
|||
Drug Name |
SECOCULARIDINE
|
|||
Synonyms |
secocularidine; CHEMBL508081
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H23NO4
|
|||
Canonical SMILES |
CN(C)CCC1=C2C=CC3=CC(=C(C=C3OC2=C(C=C1)O)OC)OC
|
|||
InChI |
1S/C20H23NO4/c1-21(2)10-9-13-6-8-16(22)20-15(13)7-5-14-11-18(23-3)19(24-4)12-17(14)25-20/h5-8,11-12,22H,9-10H2,1-4H3
|
|||
InChIKey |
DBGGUODEECPLSS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes. J Nat Prod. 1995 Oct;58(10):1475-84. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.